Results 131 to 140 of about 42,003 (148)

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial

Circulation, 2023
Peter S Hall, Iain R Macpherson, Morag MacLean   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Beta-1-adrenergic-receptor-antagonists/beta-adrenergic-receptor-antagonists

Reactions Weekly
openaire   +1 more source

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

New England Journal of Medicine, 2002
Jane F Apperley, Barbara J Bain, Andrew Chase   +2 more
exaly  

Relative Increase of T Cells Expressing the Gamma/Delta Rather Than the Alpha/Beta Receptor in Ataxia-Telangiectasia

New England Journal of Medicine, 1990
Carlo Gaetano, Massimo Fiorilli
exaly  

Beta-Adrenergic Receptor Blocking Drugs

New England Journal of Medicine, 1966
exaly   +2 more sources

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptor

Cell, 1993
Peter ten Dijke
exaly